Daiichi Sankyo has signed an exclusive agreement with Coherus BioSciences to develop and commercialize biosimilar candidates in certain Asian countries including Japan. The collaboration will focus on the development, manufacturing and ...
Tags: Daiichi Sankyo, Coherus BioSciences, biosimilar candidates